Dr. Scullin is a materials entrepreneur who has pioneered several new materials into commercialization. He is currently CEO at MycoWorks, the leader in the field of fine mycelium materials (Reishi™). He is also the co-founder and board member of a stealth-mode materials company. In 2008, Dr. Scullin founded Alphabet Energy, the leader in the field of thermoelectric products for waste-heat recovery, and sold that company in 2019. As its Chief Executive, Dr. Scullin led Alphabet Energy from initial concept through technology development and revenue growth for the world’s first commercial thermoelectric waste-heat recovery generators. Dr. Scullin has extensive experience developing strategic corporate partnerships and selling into industries including fashion, luxury, oil & gas, automotive, steel, process heating, defense, and consumer hardware, as well as in team-building, intellectual property, product management, and venture financing. Dr. Scullin has raised over US$80 million from leading worldwide venture, corporate, private equity, angel, and debt investors. He has won numerous awards for innovation and entrepreneurship including the World Economic Forum Technology Pioneer award and was named to Forbes 30 Under 30. Prior to founding Alphabet Energy, Inc., Dr. Scullin held positions at X/Seed Capital, IBM, and General Motors. He received his Ph.D. from the University of California, Berkeley in Materials Science where his work was highly cited in leading scientific journals including Nature Materials, and a B.S.E. in Materials Science from the University of Pennsylvania, Magna Cum Laude. He is an avid cyclist and a former DJ.
Did you know?
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.